299 related articles for article (PubMed ID: 15725044)
1. A meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure.
Baguet JP; Robitail S; Boyer L; Debensason D; Auquier P
Am J Cardiovasc Drugs; 2005; 5(2):131-40. PubMed ID: 15725044
[TBL] [Abstract][Full Text] [Related]
2. Updated meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure.
Baguet JP; Legallicier B; Auquier P; Robitail S
Clin Drug Investig; 2007; 27(11):735-53. PubMed ID: 17914893
[TBL] [Abstract][Full Text] [Related]
3. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2015 Feb; 33(2):195-211. PubMed ID: 25485720
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Hypertensive Patients With Diabetes and Microalbuminuria With Combination Indapamide SR/Amlodipine: Retrospective Analysis of NESTOR.
Hanon O; Boully C; Caillard L; Labourée F; Cochiello S; Chaussade E
Am J Hypertens; 2015 Aug; 28(8):1064-71. PubMed ID: 25628416
[TBL] [Abstract][Full Text] [Related]
5. Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study.
London G; Schmieder R; Calvo C; Asmar R
Am J Hypertens; 2006 Jan; 19(1):113-21. PubMed ID: 16461202
[TBL] [Abstract][Full Text] [Related]
6. Adult hypertension: reducing cardiovascular morbidity and mortality.
Prescrire Int; 2005 Feb; 14(75):25-33. PubMed ID: 15751180
[TBL] [Abstract][Full Text] [Related]
7. Intraclass differences among antihypertensive drugs.
Feldman RD; Hussain Y; Kuyper LM; McAlister FA; Padwal RS; Tobe SW
Annu Rev Pharmacol Toxicol; 2015; 55():333-52. PubMed ID: 25251994
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.
Levi-Marpillat N; Macquin-Mavier I; Tropeano AI; Parati G; Maison P
Hypertens Res; 2014 Jun; 37(6):585-90. PubMed ID: 24671016
[TBL] [Abstract][Full Text] [Related]
9. [Change from ACE inhibitor, Ca-antagonist or beta-blocker to candesartan cilexetil: better efficacy and tolerance. SWITCH study (German study segment)].
Baumgart P; Reismann J; Pohlmeyer H; Düsing R
Dtsch Med Wochenschr; 2001 May; 126(19):547-50. PubMed ID: 11402910
[TBL] [Abstract][Full Text] [Related]
10. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.
Scheen AJ
Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153
[TBL] [Abstract][Full Text] [Related]
11. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
Lacourcière Y; Neutel JM; Schumacher H
Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
[TBL] [Abstract][Full Text] [Related]
12. Nebivolol for the Treatment of Essential Systemic Arterial Hypertension: A Systematic Review and Meta-Analysis.
Seleme VB; Marques GL; Mendes AEM; Rotta I; Pereira M; Júnior EL; da Cunha CLP
Am J Cardiovasc Drugs; 2021 Mar; 21(2):165-180. PubMed ID: 32710438
[TBL] [Abstract][Full Text] [Related]
13. Association of the optic disc structure with the use of antihypertensive medications: the thessaloniki eye study.
Harris A; Topouzis F; Wilson MR; Founti P; Kheradiya NS; Anastasopoulos E; Gong G; Yu F; Jonescu-Cuypers CP; Pappas T; Koskosas A; Coleman AL
J Glaucoma; 2013 Sep; 22(7):526-31. PubMed ID: 22411020
[TBL] [Abstract][Full Text] [Related]
14. Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.
Bakris GL; Cooper-Dehoff RM; Zhou Q; Kupfer S; Champion A; Pepine CJ;
Am J Cardiovasc Drugs; 2007; 7 Suppl 1():25-9. PubMed ID: 19845074
[TBL] [Abstract][Full Text] [Related]
15. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection.
Gosse P
Expert Rev Cardiovasc Ther; 2006 May; 4(3):319-33. PubMed ID: 16716093
[TBL] [Abstract][Full Text] [Related]
16. Treating essential hypertension. The first choice is usually a thiazide diuretic.
Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive efficacy of indapamide SR in hypertensive patients uncontrolled with a background therapy: the NATIVE study.
Akram J; Sheikh UE; Mahmood M; Donnelly R
Curr Med Res Opin; 2007 Dec; 23(12):2929-36. PubMed ID: 17931463
[TBL] [Abstract][Full Text] [Related]
18. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacies of antihypertensive drugs.
Aursnes I; Tvete IF; Gåsemyr J; Natvig B
Scand Cardiovasc J; 2003 May; 37(2):72-9. PubMed ID: 12775305
[TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
Petrella R; Michailidis P
Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]